U.S. jury orders massive awards against Takeda, Eli Lilly

04/8/2014 | Reuters

A jury in Louisiana awarded $6 billion in damages from Takeda Pharmaceutical, plus $3 billion in punitive damages against Eli Lilly & Co., for claims that the companies hid cancer risks associated with the diabetes drug Actos. Takeda said it would challenge the finding through the appeal process. Another U.S. judge in May nullified a $6.5 million award against Takeda, citing lack of evidence that the drug caused cancer.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA